Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1
mBio · 2023
DOI: 10.1128/mbio.00867-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von An Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Virus Diseases, Interferon Type I. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China.
Abstract (Originalsprache)
The host innate immune system’s defense against viral infections depends heavily on type I interferon (IFN-I) production. Research into the mechanisms of virus-host interactions is essential for developing novel antiviral therapies. In this study, we compared the effect of the five members of the microRNA-200 (miR-200) family on IFN-I production during viral infection and found that miR-200b-3p displayed the most pronounced regulatory effect. During viral infection, we discovered that the transcriptional level of microRNA-200b-3p (miR-200b-3p) increased with the infection of influenza virus (IAV) and vesicular stomatitis virus (VSV), and miR-200b-3p production was modulated by the activation of the ERK and p38 pathways. We identified cAMP response element binding protein (CREB) as a novel transcription factor that binds to the miR-200b-3p promoter. MiR-200b-3p reduces NF-κB and IRF3-mediated IFN-I production by targeting the 3′ untranslated region (3′ UTR) of TBK1 mRNA. Applying miR-200b-3p inhibitor enhances IFN-I production in IAV and VSV-infected mouse models, thus inhibiting viral replication and improving mouse survival ratio. Importantly, in addition to IAV and VSV, miR-200b-3p inhibitors exhibited potent antiviral effects against multiple pathogenic viruses threatening human health worldwide. Overall, our study suggests that miR-200b-3p might be a potential therapeutic target for broad-spectrum antiviral therapy. IMPORTANCE The innate immune response mediated by type I interferon (IFN-I) is essential for controlling viral replication. MicroRNAs (miRNAs) have been found to regulate the IFN signaling pathway. In this study, we describe a novel function of miRNA-200b-3p in negatively regulating IFN-I production during viral infection. miRNA-200b-3p was upregulated by the MAPK pathway activated by IAV and VSV infection. The binding of miRNA-200b-3p to the 3′ UTR of TBK1 mRNA reduced IFN-I activation mediated by IRF3 and NF-κB. Application of miR-200b-3p inhibitors exhibited potent antiviral effects against multiple RNA and DNA viruses. These results provide fresh insight into understanding the impact of miRNAs on host-virus interactions and reveal a potential therapeutic target for common antiviral intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
- Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University , Wuhan, China.
- Hubei Hongshan Laboratory , Wuhan, China.
ORCID-Profile: Ling Zhao
Förderung
- MOST | National Key Research and Development Program of China
Zitieren
APA
Fang, A., Yuan, Y., Sui, B., Wang, Z., Zhang, Y., Zhou, M., Chen, H., Fu, Z. F., & Zhao, L. (2023). Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1. mBio. https://doi.org/10.1128/mbio.00867-23
Vancouver
Fang A, Yuan Y, Sui B, Wang Z, Zhang Y, Zhou M, et al. Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1. mBio. 2023. doi:10.1128/mbio.00867-23
BibTeX
@article{Fang2023,
author = {Fang, An and Yuan, Yueming and Sui, Baokuen and Wang, Zhihui and Zhang, Yuan and Zhou, Ming and Chen, Huanchun and Fu, Zhen F and Zhao, Ling},
title = {Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.00867-23}
}
EUVIMED